Early research (Phase 1)Study completedNCT01273922
What this trial is testing
Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
Who this might be right for
Staphylococcal InfectionsCandidiasis
NovaDigm Therapeutics, Inc. 40